Analysis and Discussion Concerning Death

The analysis and discussion concerning death as intended by the Researcher depicts that death is an irreversible condition or state encountered by beings (all living creatures), due to a total dysfunction of the body organs. Such an irreversible condition is an enemy of human beings, which supersedes humanity, causing unexpected changes in life. It came as a punishment of abusing the supernatural power and finally it became a fact of not living forever. By the use of different literatures, Interviews and Documents, the research explored diverse concerns of death and drew its conclusion. Some of those concerns are “how is death detected? What are the causatives of death? Does death have its remedy? Where are dead people? Why do we bury the dead? And what is next after death?” The findings reveal that Doctors prove death by assessing and measuring the vital signs such as Blood Pressure, Pulse Rate, Respiratory Rate and Body Temperature. Moreover, the causatives of death include chronic pulmonary obstructive disease, ischemia, stroke, dehydration, infections and pain as well as old age. Those who encounter death are laid in the graves because God commanded it to be so and they produce unpleasant smell and stink. The remedy of it depends on the supernatural power that is believed to have ability of restoring the lost lives at consummation. That’s why Christians believe that on the second coming of Jesus Christ, all the dead shall rise. Hence, human beings have to be kin enough in lifetime, so that they may prolong a bit their lifespan through observance of health principles and guidelines.

Role of serum magnesium in acute exacerbations of chronic obstructive pulmonary disease

Background: This prospective study was done to assess the association between serum magnesium deficiency and its effect on exacerbation of chronic pulmonary obstructive disease (COPD), and also to probably suggest a cut-off level which may be useful for predicting clinical outcomes and serving as a target value for therapeutic intervention. Methods: This study was conducted among 100 patients in a tertiary hospital, who were diagnosed with COPD, and their serum magnesium levels were measured when they presented to the hospital during routine check-up (stable) and during an exacerbation. Their PEFR and oxygen saturation were also measured to assess severity. Results: Out of 100 patients studied, 91 were males and 9 were females, of which 38 of them were aged 60 or below and 62 of them aged 61 and above. The average serum magnesium levels of patients presenting during routine check-up was 2.08 mg/dl (below 60) and 2.06 mg/dl (above 61) as compared to values during an exacerbation which was 1.58 mg/dl (below 60) and 1.60 mg/dl (above 60) which was significant. Our study also determined a serum magnesium cut-off value averaging 1.65 mg/dl, which may be useful therapeutic target for intervention.Conclusions: Serum low serum magnesium levels has a definite association with exacerbations of COPD. Earlier therapeutic interventions may help in decreasing the episodes of exacerbation. A significant reduction of magnesium levels may correlate with severity of airway obstruction.

Comorbidities, COPD and COVID 19

Coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 is one of the most pressing health care concerns in 2020. The continually growing number of new cases, the global outspread of the virus and the severity of the disease determined the World Health Organization to declare the outbreak a pandemic. Twenty per cent of the patients present severe and critical forms that frequently require oxygen supplementation and intensive care unit admission. That is why, to provide optimal care, it is imperative to identify at-risk patients. Patients with associated chronic diseases are more prone to develop severe and critical forms of the infection. Although the chronic pulmonary obstructive disease is present only in a limited number of coronavirus disease 2019 patients, it is most commonly associated with lung disease and a poor outcome than other comorbidities.